Interestingly, our data indicated that Tregs from the tumor tissues of lung cancer patients without lymphatic invasion or distant metastasis expressed more GARP than those from lung cancer patients with lymphatic invasion or distant metastasis, and Tregs from patients in stages I and II also had more GARP expression than those from patients in stages III and IV. Here, LRRC32 is linked to lung carcinoma.